0001226555-18-000001.txt : 20180619 0001226555-18-000001.hdr.sgml : 20180619 20180618173821 ACCESSION NUMBER: 0001226555-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180619 DATE AS OF CHANGE: 20180618 EFFECTIVENESS DATE: 20180619 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ICONIC THERAPEUTICS INC CENTRAL INDEX KEY: 0001226555 IRS NUMBER: 161653625 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-314821 FILM NUMBER: 18905546 BUSINESS ADDRESS: STREET 1: 7000 SHORELINE COURT STREET 2: SUITE 270 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-437-1000 MAIL ADDRESS: STREET 1: 7000 SHORELINE COURT STREET 2: SUITE 270 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 D 1 primary_doc.xml X0708 D LIVE 0001226555 ICONIC THERAPEUTICS INC 7000 SHORELINE COURT SUITE 270 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 650-437-1000 DELAWARE None None Corporation true William Greene 7000 Shoreline Court Suite 270 South San Francisco CA CALIFORNIA 94080 Executive Officer Director Kirk Dornbush 7000 Shoreline Court Suite 270 South San Francisco CA CALIFORNIA 94080 Director Todd Foley 7000 Shoreline Court Suite 270 South San Francisco CA CALIFORNIA 94080 Director Julia Gregory 7000 Shoreline Court Suite 270 South San Francisco CA CALIFORNIA 94080 Director Bruce Robertson 7000 Shoreline Court Suite 270 South San Francisco CA CALIFORNIA 94080 Director Peter Hirth 7000 Shoreline Court Suite 270 South San Francisco CA CALIFORNIA 94080 Director Biotechnology Decline to Disclose 06b false 2018-06-05 false true true Convertible Promissory Notes; Preferred Stock issuable upon conversion; Common Stock issuable upon conversion false 0 10900000 4109317 6790683 false 36 0 0 500000 true Proceeds will be used for general corporate purposes including, but not limited to, executive salaries. false ICONIC THERAPEUTICS INC /s/ William L. Greene William L. Greene CEO 2018-06-15